| Literature DB >> 33119139 |
Joshua P Vogel1,2, Britta Tendal2, Michelle Giles3,4,5,6,7, Clare Whitehead5,8, Wendy Burton9, Samantha Chakraborty10, Saskia Cheyne11, Teena Downton12, David Fraile Navarro13, Glenda Gleeson14, Adrienne Gordon15,16,17, Jenny Hunt18, Jackie Kitschke19, Steven McDonald2, Nolan McDonnell20, Philippa Middleton21,22, Tanya Millard2, Melissa Murano2, Jeremy Oats23, Rhiannon Tate2, Heath White2, Julian Elliott2,3, Vijay Roach24, Caroline S E Homer1,25.
Abstract
To date, 18 living recommendations for the clinical care of pregnant and postpartum women with COVID-19 have been issued by the National COVID-19 Clinical Evidence Taskforce. This includes recommendations on mode of birth, delayed umbilical cord clamping, skin-to-skin contact, breastfeeding, rooming-in, antenatal corticosteroids, angiotensin-converting enzyme inhibitors, disease-modifying treatments (including dexamethasone, remdesivir and hydroxychloroquine), venous thromboembolism prophylaxis and advanced respiratory support interventions (prone positioning and extracorporeal membrane oxygenation). Through continuous evidence surveillance, these living recommendations are updated in near real-time to ensure clinicians in Australia have reliable, evidence-based guidelines for clinical decision-making. Please visit https://covid19evidence.net.au/ for the latest recommendation updates.Entities:
Keywords: Australia; COVID-19; guidelines; perinatal care; pregnancy
Year: 2020 PMID： 33119139 DOI： 10.1111/ajo.13270
Source DB: PubMed Journal: Aust N Z J Obstet Gynaecol ISSN： 0004-8666 Impact factor: 2.100